The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.7M data for 1.2M Compounds and 9.0K Targets. Of those, 1,244K data for 572K Compounds and 4.4K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

57 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of SOAT2 inhibitors from synthetic small molecules.EBI
Kitasato University
Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton.EBI
Kitasato University
Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.EBI
Kitasato University
Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists.EBI
Kitasato University
Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen asd opioid receptor inverse agonists.EBI
Kitasato University
Design, synthesis, and structure-activity relationship of novel opioid¿ receptor selective agonists:a-iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.EBI
Kitasato University
Synthesis and Pharmacology of a Novel¿ Opioid Receptor (KOR) Agonist with a 1,3,5-Trioxazatriquinane Skeleton.EBI
Kitasato University
Creation of Customized Bioactivity within a 14-Membered Macrolide Scaffold: Design, Synthesis, and Biological Evaluation Using a Family-18 Chitinase.EBI
Kitasato University
Synthesis and biological activity of 5-(4-methoxyphenyl)-oxazole derivatives.EBI
Kitasato University
Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologies.EBI
Kitasato University
Novel delta opioid receptor agonists with oxazatricyclodecane structure.EBI
Kitasato University
Human acidic mammalian chitinase as a novel target for anti-asthma drug design using in silico screening.EBI
Kitasato University
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.EBI
Kitasato University
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2.EBI
Kitasato University
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.EBI
Kitasato University
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.EBI
Kitasato University
The effect of 17-N substituents on the activity of the opioid¿ receptor in nalfurafine derivatives.EBI
Kitasato University
Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.EBI
Kitasato University
Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.EBI
Kitasato University
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 3: synthesis of novel triplet drugs with the bis(epoxymethano) or bis(dimethylepoxymethano) structure (double-capped triplet).EBI
Kitasato University
Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: part 3, novel propellane derivatives with pentacyclic skeletons.EBI
Kitasato University
Essential structure of opioid¿ receptor agonist nalfurafine for binding to the¿ receptor 3: synthesis of decahydro(iminoethano)phenanthrene derivatives with an oxygen functionality at the 3-position and their pharmacologies.EBI
Kitasato University
Synthesis of quinolinomorphinan derivatives as highly selectived opioid receptor ligands.EBI
Kitasato University
Essential structure of opioid¿ receptor agonist nalfurafine for binding to the¿ receptor 2: synthesis of decahydro(iminoethano)phenanthrene derivatives and their pharmacologies.EBI
Kitasato University
Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain.EBI
Kitasato University
Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.EBI
Kitasato University
Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: part 1.EBI
Kitasato University
Identification of the three-dimensional pharmacophore of kappa-opioid receptor agonists.EBI
Kitasato University
Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.EBI
Kitasato University
Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin.EBI
Kitasato University
Design and synthesis of novel delta opioid receptor agonists and their pharmacologies.EBI
Kitasato University
Synthesis of a new opioid ligand having the oxabicyclo[3.2.1]octane skeleton using a new rearrangement reaction.EBI
Kitasato University
Synthesis of N-isobutylnoroxymorphone from naltrexone by a selective cyclopropane ring opening reaction.EBI
Kitasato University
Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology.EBI
Kitasato University
Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.EBI
Kitasato University
Synthesis of quinolinomorphinan-4-ol derivatives asd opioid receptor agonists.EBI
Kitasato University
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. Part 2: Synthesis of novel triplet drugs with the epoxymethano structure (capped homotriplet).EBI
Kitasato University
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons.EBI
Kitasato University
Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies.EBI
Kitasato University
Design and synthesis of KNT-127, ad-opioid receptor agonist effective by systemic administration.EBI
Kitasato University
Synthesis of pyrrolomorphinan derivatives as kappa opioid agonists.EBI
Kitasato University
NMR spectroscopy and computational analysis of interaction between Serratia marcescens chitinase B and a dipeptide derived from natural-product cyclopentapeptide chitinase inhibitor argifin.EBI
Kitasato University
Investigation of Beckett-Casy model 2: synthesis of novel 15-16 nornaltrexone derivatives and their pharmacology.EBI
Kitasato University
Investigation of Beckett-Casy model 1: synthesis of novel 16,17-seco-naltrexone derivatives and their pharmacology.EBI
Kitasato University
Aerobic oxidation of indolomorphinan without the 4,5-epoxy bridge and subsequent rearrangement of the oxidation product to spiroindolinonyl-C-normorphinan derivative.EBI
Kitasato University
Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens.EBI
Kitasato University
Argifin; efficient solid phase total synthesis and evaluation of analogues of acyclic peptide.EBI
Kitasato University
Computational analysis of the binding affinities of the natural-product cyclopentapeptides argifin and argadin to chitinase B from Serratia marcescens.EBI
Kitasato University
Discovery of ? opioid receptor full agonists lacking a basic nitrogen atom and their antidepressant-like effects.EBI
Kitasato University
Inhibition of cholesteryl ester synthesis by polyacetylenes from Atractylodes rhizome.EBI
Kitasato University
Synthetic conversion of ACAT inhibitor to acetylcholinesterase inhibitor.EBI
Kitasato University
Inhibition of neutral lipid synthesis by avarols from a marine sponge.EBI
Kitasato University
The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, ? opioid receptor agonists.EBI
Kitasato University
Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton having a 7-amide side chain and their pharmacologies.EBI
Kitasato University
Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities.EBI
Kitasato University
Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea.BDB
Kitasato University